wy 41770 has been researched along with levamisole in 1 studies
Studies (wy 41770) | Trials (wy 41770) | Recent Studies (post-2010) (wy 41770) | Studies (levamisole) | Trials (levamisole) | Recent Studies (post-2010) (levamisole) |
---|---|---|---|---|---|
5 | 0 | 0 | 4,520 | 580 | 620 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carlson, RP; Datko, LJ; Lewis, AJ; O'Neill-Davis, L | 1 |
1 other study(ies) available for wy 41770 and levamisole
Article | Year |
---|---|
Immunomodulating activity of Wy-41,770 (5H-dibenzo[A,D]cyclohepten-5-ylidene) acetic acid.
Topics: Acetates; Animals; Arthritis, Experimental; Dibenzocycloheptenes; Encephalomyelitis, Autoimmune, Experimental; Erythrocytes; Guinea Pigs; Hypersensitivity, Delayed; Immune System; Immunoglobulin M; Indomethacin; Levamisole; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Rats; Rats, Inbred Lew | 1986 |